As the new CP variants identified in N. edaphicum CCNP1411 inhibited the activity of trypsin or chymotrypsin at low concentrations and were inactive against the other tested enzymes and MCF-7 breast cancer cells, their possible use as therapeutic agents should be further explored. The gene discussed is CP; the disease is breast cancer.